<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><generator uri="https://jekyllrb.com/" version="4.4.1">Jekyll</generator><link href="http://localhost:4000/feed.xml" rel="self" type="application/atom+xml" /><link href="http://localhost:4000/" rel="alternate" type="text/html" hreflang="en" /><updated>2026-01-13T20:35:26-05:00</updated><id>http://localhost:4000/feed.xml</id><title type="html">Lauren Song</title><subtitle>Hydejack is a boutique Jekyll theme for hackers, nerds, and academics, with a focus on personal sites that are meant to impress.
</subtitle><author><name>Lauren Song</name><email>ahyeonsong@ufl.edu</email></author><entry><title type="html">DRP | Optimal Control</title><link href="http://localhost:4000/projects/2025-12-20-optimalcontrol/" rel="alternate" type="text/html" title="DRP | Optimal Control" /><published>2025-12-20T00:00:00-05:00</published><updated>2026-01-13T13:01:43-05:00</updated><id>http://localhost:4000/projects/optimalcontrol</id><content type="html" xml:base="http://localhost:4000/projects/2025-12-20-optimalcontrol/"><![CDATA[<!-- Version 9 is the most complete version of Hydejack yet.
{:.lead} -->

<div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>Note: Use a desktop browser to view the interactive table of contents.
</code></pre></div></div>
<ul class="large-only" id="markdown-toc">
  <li><a href="#how-to-mathematically-optimize-drug-regimens-using-optimal-control" id="markdown-toc-how-to-mathematically-optimize-drug-regimens-using-optimal-control">How to mathematically optimize drug regimens using optimal control</a>    <ul>
      <li><a href="#week-1" id="markdown-toc-week-1">Week 1</a></li>
    </ul>
  </li>
</ul>

<p>Directed Reading Program (DRP) is mentoring initiative designed to give motivated undergraduates an opportunity to explore advanced mathematics topics under the guidance of a graduate stduent mentor.</p>

<p><a href="https://math.ufl.edu/drp/">Click this to learn more about DRP</a></p>

<h2 id="how-to-mathematically-optimize-drug-regimens-using-optimal-control">How to mathematically optimize drug regimens using optimal control</h2>
<blockquote>
  <p>üî¨ Kyle Adams, Julia Bruner, Alexandra Haddad, Drew Nelson, <strong>Lauren Song</strong>, Kayla Adams</p>
</blockquote>

<ul>
  <li><a href="/assets/img/drp/DRP-Reading.pdf">DRP Reading.pdf</a></li>
  <li><a href="https://pubmed.ncbi.nlm.nih.gov/29411198/">NIH Permalink</a></li>
</ul>

<p>Meetings: Every Tuesday Period 7(1:55-2:45) in LIT 368</p>

<h3 id="week-1">Week 1</h3>
<p>Reading</p>
<ul>
  <li>
    <p>‚ÄúIntroduction‚Äù Section of <i>How to mathematically optimize drug regimens using optimal control, referred to as ‚Äúmain paper.‚Äù</i></p>
  </li>
  <li>
    <p>Guied Questions</p>
    <ol>
      <li>Why is optimal control preferred to standard ‚Äúguess-and-check‚Äù methods?</li>
      <li>How ‚Äúgood‚Äù does a model have to be to apply optimal control to it?</li>
      <li>What does QSP stand for? Compare optimal control systems to QSP models.</li>
      <li>Take a look at the outline in figure 1. What questions or comments about it can you come up with?</li>
    </ol>
  </li>
</ul>]]></content><author><name>Lauren Song</name><email>ahyeonsong@ufl.edu</email></author><category term="projects" /><summary type="html"><![CDATA["Direct Reading Program in Mathematics at University of Florida"]]></summary></entry><entry><title type="html">Cologuard vs. Colonoscopy</title><link href="http://localhost:4000/projects/2025-04-23-coloncancer/" rel="alternate" type="text/html" title="Cologuard vs. Colonoscopy" /><published>2025-04-23T00:00:00-04:00</published><updated>2026-01-13T18:57:13-05:00</updated><id>http://localhost:4000/projects/coloncancer</id><content type="html" xml:base="http://localhost:4000/projects/2025-04-23-coloncancer/"><![CDATA[<p>Assessing the Clinical Effectiveness of Cologuard vs. Colonoscopy in Early Detection of Colorectal Cancer.</p>

<blockquote>
  <p>üî¨ Chandler Castillon, <strong>Lauren Song</strong>, Amanda Martin, Shriya Anand, Samia Khan, Riya Pandey, Praval Ghanta</p>
</blockquote>

<p><strong>Presented at:</strong>  <a href="#">Undergraduate Research Conference at the University of South Florida</a>.</p>

<p><strong>Timeline:</strong> Aug 2024 - April 2025</p>

<p><strong>Key Tools:</strong> Rayyan</p>

<p><strong>Quick Links:</strong> <a href="/assets/img/logo/URS-Coloncancer-Poster.png">View Poster</a></p>

<div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>Note: Use a desktop browser to view the interactive table of contents.
</code></pre></div></div>
<ul class="large-only" id="markdown-toc">
  <li><a href="#research-overview" id="markdown-toc-research-overview">Research Overview</a>    <ul>
      <li><a href="#abstract" id="markdown-toc-abstract">Abstract</a></li>
      <li><a href="#introduction" id="markdown-toc-introduction">Introduction</a></li>
      <li><a href="#methods-and-materials" id="markdown-toc-methods-and-materials">Methods and Materials</a>        <ul>
          <li><a href="#figure-1---flowchart-of-screening-proceses" id="markdown-toc-figure-1---flowchart-of-screening-proceses">Figure 1 - Flowchart of screening proceses</a></li>
          <li><a href="#exclusion-and-inclusion-criteria" id="markdown-toc-exclusion-and-inclusion-criteria">Exclusion and Inclusion Criteria</a></li>
        </ul>
      </li>
      <li><a href="#results" id="markdown-toc-results">Results</a>        <ul>
          <li><a href="#figure-2" id="markdown-toc-figure-2">Figure 2</a></li>
          <li><a href="#figure-3" id="markdown-toc-figure-3">Figure 3</a></li>
          <li><a href="#figure-4" id="markdown-toc-figure-4">Figure 4</a></li>
        </ul>
      </li>
      <li><a href="#discussion" id="markdown-toc-discussion">Discussion</a></li>
      <li><a href="#conclusions" id="markdown-toc-conclusions">Conclusions</a></li>
    </ul>
  </li>
</ul>

<h2 id="research-overview">Research Overview</h2>
<p><br /></p>

<h3 id="abstract">Abstract</h3>
<p>In the past ten years, there has been a rise in the implementation of non-invasive colon cancer screening such as multitarget-stool DNA tests (MT-sDNA), also known as cologuard, fecal immunochemical tests (FIT), and tumor/blood based markers. This literature review aims to assess the clinical effectiveness of multi-target stool DNA tests (cologuard) versus the clinical effectiveness of a colonoscopy. Thirty-six articles were obtained using the reference management software, Endnote, and the National Institute of Health‚Äôs medical database to locate articles relating to cologuard/MT-sDNA and colonoscopies. This review found that cologuard was more effective at detecting precancerous and cancerous growths at a higher specificity but lower accuracy than colonoscopy. Additionally, adherence to preparation levels affected colonoscopy detection rates. Conducting a MT-sDNA test followed by a colonoscopy is far more effective at reducing colorectal cancer (CRC) incidence and mortality. The results obtained demonstrate that MT-sDNA tests are slightly more effective at detecting colon cancer and precancerous growths, however, without a follow-up colonoscopy, growths that were detected cannot be removed. By combining both MT-sDNA tests and colonoscopies together, CRC incidence and mortality can dramatically decrease.</p>

<h3 id="introduction">Introduction</h3>
<p>Colorectal cancer (CRC) is a serious public health concern and remains among the leading causes of cancer mortality globally. Screening for early detection of colorectal cancer is crucial in the prevention of incidence and mortality.</p>

<p>Two common employed CRC screening methods are colonoscopy and multi-target sstool DNA (MT-sDNA), or Cologuard. Both methods are to detect CRC at an early stage to improve patient outcomes. Colonoscopy is an invasive procedure in which a felxible tube with a camera is inserted into the colon to visually inspect the whole bowel for irregularities. It offers the ability to immediately remove detected polyps and is generally recommended every ten years for average-risk patients. In contrast, the Mt-sDNA test is a non-invasive stool test that detects occult blood and genetic markers for CRC. This testing is conducted at home and does not involve sedation or bowel prep and is typically recommended every three years.</p>

<p>Although Cologuard can identify aberrant blood and DNA linked to precancerous lesions and cancer with convenience, it may miss some advanced adenomas and has a greater false-positive rate. Colonoscopy enables direct vision, biopsy, and removal of polyps, offering advantages for both diagnosis and prevention due to higher sensitivity.</p>

<p>The purpose of this research project is to help determine the clinical effectiveness of Cologuard and colonoscopy when screening for colon cancer.</p>

<h3 id="methods-and-materials">Methods and Materials</h3>

<p><strong>PRISMA 2020</strong> flow diagram for new systematic reviews which included searches of databases and registers only</p>

<h4 id="figure-1---flowchart-of-screening-proceses">Figure 1 - Flowchart of screening proceses</h4>
<style>
  .prisma-box {
    fill: #ffffffff; 
    stroke: #333; 
    stroke-width: 1;
    cursor: pointer;
    transition: fill 0.2s ease-in-out;
  }
  .prisma-box:hover {
    fill: #f0f0f0; 
  }
  .prisma-text {
    font-family: Arial, sans-serif;
    font-size: 12px;
    fill: #333;
    pointer-events: none; 
  }
  .prisma-arrow {
    stroke: #333;
    stroke-width: 1;
    fill: none;
    marker-end: url(#arrowhead); 
  }
  .tooltip {
    position: absolute;
    background-color: #333;
    color: #fff;
    padding: 8px 12px;
    border-radius: 4px;
    font-size: 13px;
    pointer-events: none;
    opacity: 0;
    transition: opacity 0.2s;
    z-index: 10;
    max-width: 300px;
    line-height: 1.4;
  }
  .tooltip.active {
    opacity: 1;
  }
</style>

<div style="position: relative; width: 100%; max-width: 900px; margin: 0 auto;">
  <svg width="100%" height="800" viewBox="0 0 900 800" xmlns="http://www.w3.org/2000/svg">
    <defs>
      <marker id="arrowhead" markerWidth="10" markerHeight="7" refX="0" refY="3.5" orient="auto">
        <polygon points="0 0, 10 3.5, 0 7" fill="#333" />
      </marker>
    </defs>

    <script type="application/json" id="prismaData">
      {
        "identification": {
          "title": "Identification of records",
          "total": "4487 records identified from: Endnote Databases (n=1) - National Institute of Health (NIH), 4487 imported articles",
          "removed": "Records removed before screening (n=2401): Duplicate records removed (n=1212), Records marked as ineligible by automation tools (n=717), Records removed for other reasons (n=472)"
        },
        "screening": {
          "title": "Records screened",
          "screened": "Records screened (n=3770)",
          "excluded": "Records excluded (n=3541) (Second round of screening eliminated all articles before 2020 with a few exceptions)"
        },
        "retrieval": {
          "title": "Reports sought for retrieval",
          "sought": "Reports sought for retrieval (n=229)",
          "not_retrieved": "Reports not retrieved (n=144)"
        },
        "eligibility": {
          "title": "Reports assessed for eligibility",
          "assessed": "Reports assessed for eligibility (n=85)",
          "excluded": "Reports excluded (n=49). Reasons: Refer to exclusion and inclusion criteria"
        },
        "included": {
          "title": "Studies included in review",
          "included": "Studies included in review (n=36)"
        }
      }
    </script>

    <rect x="50" y="50" width="250" height="100" class="prisma-box" id="box-identification" data-category="identification"></rect>
    <text x="175" y="80" text-anchor="middle" class="prisma-text">Identification of records</text>
    <text x="175" y="105" text-anchor="middle" class="prisma-text">from databases (n=4487)</text>

    <rect x="600" y="50" width="250" height="100" class="prisma-box" id="box-removed" data-category="identification"></rect>
    <text x="725" y="80" text-anchor="middle" class="prisma-text">Records removed before screening</text>
    <text x="725" y="105" text-anchor="middle" class="prisma-text">(n=2401)</text>

    <line x1="300" y1="100" x2="600" y2="100" class="prisma-arrow"></line>

    <line x1="175" y1="150" x2="175" y2="200" class="prisma-arrow"></line>

    <rect x="50" y="200" width="250" height="100" class="prisma-box" id="box-screening" data-category="screening"></rect>
    <text x="175" y="230" text-anchor="middle" class="prisma-text">Records screened (n=3770)</text>

    <rect x="600" y="200" width="250" height="100" class="prisma-box" id="box-excluded-screening" data-category="screening"></rect>
    <text x="725" y="230" text-anchor="middle" class="prisma-text">Records excluded (n=3541)</text>

    <line x1="300" y1="250" x2="600" y2="250" class="prisma-arrow"></line>

    <line x1="175" y1="300" x2="175" y2="350" class="prisma-arrow"></line>

    <rect x="50" y="350" width="250" height="100" class="prisma-box" id="box-retrieval" data-category="retrieval"></rect>
    <text x="175" y="380" text-anchor="middle" class="prisma-text">Reports sought for retrieval</text>
    <text x="175" y="405" text-anchor="middle" class="prisma-text">(n=229)</text>

    <rect x="600" y="350" width="250" height="100" class="prisma-box" id="box-not-retrieved" data-category="retrieval"></rect>
    <text x="725" y="380" text-anchor="middle" class="prisma-text">Reports not retrieved (n=144)</text>

    <line x1="300" y1="400" x2="600" y2="400" class="prisma-arrow"></line>

    <line x1="175" y1="450" x2="175" y2="500" class="prisma-arrow"></line>

    <rect x="50" y="500" width="250" height="100" class="prisma-box" id="box-eligibility" data-category="eligibility"></rect>
    <text x="175" y="530" text-anchor="middle" class="prisma-text">Reports assessed for eligibility</text>
    <text x="175" y="555" text-anchor="middle" class="prisma-text">(n=85)</text>

    <rect x="600" y="500" width="250" height="100" class="prisma-box" id="box-excluded-eligibility" data-category="eligibility"></rect>
    <text x="725" y="530" text-anchor="middle" class="prisma-text">Reports excluded (n=49)</text>

    <line x1="300" y1="550" x2="600" y2="550" class="prisma-arrow"></line>

    <line x1="175" y1="600" x2="175" y2="650" class="prisma-arrow"></line>

    <rect x="50" y="650" width="250" height="100" class="prisma-box" id="box-included" data-category="included"></rect>
    <text x="175" y="680" text-anchor="middle" class="prisma-text">Studies included in review</text>
    <text x="175" y="705" text-anchor="middle" class="prisma-text">(n=36)</text>
  </svg>

  <div class="tooltip" id="prisma-tooltip"></div>
</div>

<script>
  document.addEventListener('DOMContentLoaded', function() {
    const tooltip = document.getElementById('prisma-tooltip');
    const prismaData = JSON.parse(document.getElementById('prismaData').textContent);

    document.querySelectorAll('.prisma-box').forEach(box => {
      box.addEventListener('mouseenter', function(e) {
        const category = this.dataset.category;
        let content = '';

        if (category === 'identification') {
          if (this.id === 'box-identification') {
            content = prismaData.identification.total;
          } else if (this.id === 'box-removed') {
            content = prismaData.identification.removed;
          }
        } else if (category === 'screening') {
          if (this.id === 'box-screening') {
            content = prismaData.screening.screened;
          } else if (this.id === 'box-excluded-screening') {
            content = prismaData.screening.excluded;
          }
        } else if (category === 'retrieval') {
          if (this.id === 'box-retrieval') {
            content = prismaData.retrieval.sought;
          } else if (this.id === 'box-not-retrieved') {
            content = prismaData.retrieval.not_retrieved;
          }
        } else if (category === 'eligibility') {
          if (this.id === 'box-eligibility') {
            content = prismaData.eligibility.assessed;
          } else if (this.id === 'box-excluded-eligibility') {
            content = prismaData.eligibility.excluded;
          }
        } else if (category === 'included') {
          content = prismaData.included.included;
        }

        tooltip.innerHTML = content;
        tooltip.classList.add('active');
        updateTooltipPosition(e);
      });

      box.addEventListener('mousemove', function(e) {
        updateTooltipPosition(e);
      });

      box.addEventListener('mouseleave', function() {
        tooltip.classList.remove('active');
      });
    });

    function updateTooltipPosition(e) {
      const x = e.clientX;
      const y = e.clientY;
      const tooltipWidth = tooltip.offsetWidth;
      const tooltipHeight = tooltip.offsetHeight;

      // hover
      let newX = x + 15;
      let newY = y + 15;

      if (newX + tooltipWidth > window.innerWidth) {
        newX = x - tooltipWidth - 15;
      }
      if (newY + tooltipHeight > window.innerHeight) {
        newY = y - tooltipHeight - 15;
      }

      tooltip.style.left = `${newX}px`;
      tooltip.style.top = `${newY}px`;
    }
  });
</script>

<hr />
<h4 id="exclusion-and-inclusion-criteria">Exclusion and Inclusion Criteria</h4>
<ul>
  <li><strong>Exclusion</strong>: Case studies, testing procedures irrelevant to colonoscopy, surveys, data prior to 2000, literary reviews, animal studies.</li>
  <li><strong>Inclusion</strong>: Treatment effectiveness, broad population, limiting factors, colonoscopy primary sources, details‚Äô statistics about colorectal cancer, Cologuard, multitarget stool DNA testing, stool-based DNA methylation test.</li>
</ul>

<h3 id="results">Results</h3>
<p>Hover for details.</p>

<h4 id="figure-2">Figure 2</h4>
<p class="note">Comparison of the specificity, sensitivity, reduction in colorectal cancer (CRC) incidence, and reduction in CRC mortality between MT-sDNA (Cologuard) tests and a colonoscopy.</p>

<div style="width: 100%; max-width: 800px; margin: auto;">
  <canvas id="performanceChart"></canvas>
</div>

<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>

<script>
  (function() {
    const ctx = document.getElementById('performanceChart').getContext('2d');
    new Chart(ctx, {
      type: 'bar',
      data: {
        labels: ['Specificity', 'Sensitivity', 'Reduction in CRC Incidence', 'Reduction in CRC Mortality'],
        datasets: [
          {
            label: 'Cologuard',
            data: [0.92, 0.93, 0.57, 0.67], // Data from provided chart
            backgroundColor: '#c3c3c3ff', // Dark green matching the image
            borderWidth: 1
          },
          {
            label: 'Colonoscopy',
            data: [0.89, 0.95, 0.70, 0.68], // Data from provided chart
            backgroundColor: '#333', // Yellow matching the image
            borderWidth: 1
          }
        ]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { position: 'bottom' },
          title: {
            display: true,
            text: 'Comparison in Performance of Cologuard¬Æ and Colonoscopy'
          },
          tooltip: {
            enabled: true,
            callbacks: {
              label: function(context) {
                return context.dataset.label + ': ' + context.raw;
              }
            }
          }
        },
        scales: {
          y: {
            beginAtZero: true,
            max: 1.3,
            ticks: { stepSize: 0.1 }
          }
        }
      }
    });
  })();
</script>

<hr />

<blockquote>
  <p><em>Figure 2</em> The performance markers used for this table included the specificity, sensitivity, reduction in colorectal cancer (CRC) incidence, and reduction in CRC mortality. Both tests show similar results, with the only significant difference im reduction in CRC incidence which is higher in colonoscopies.</p>
</blockquote>

<h4 id="figure-3">Figure 3</h4>
<p class="note">Comparison of the adenoma, sessile serrated polyp, and missed adenoma rate between Cologuard and Colonoscopy.</p>

<div style="width: 100%; max-width: 800px; margin: auto;">
  <canvas id="detectionChart"></canvas>
</div>

<script>
  (function() {
    const ctx2 = document.getElementById('detectionChart').getContext('2d');
    new Chart(ctx2, {
      type: 'bar',
      data: {
        labels: ['Adenomas', 'Sessile serrated polyps', 'Missed Adenoma'],
        datasets: [
          {
            label: 'Cologuard',
            data: [0.3, 0.052, 0.18], // Data from provided chart
            backgroundColor: '#c3c3c3ff', // Dark green matching the image
            borderWidth: 1
          },
          {
            label: 'Colonoscopy',
            data: [0.228, 0.07, 0.05], // Data from provided chart
            backgroundColor: '#333', // Yellow matching the image
            borderWidth: 1
          }
        ]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { position: 'bottom' },
          title: {
            display: true,
            text: 'Cologuard¬Æ vs. Colonoscopy: Precancerous/Cancerous Growth Detection rates'
          }
        },
        scales: {
          y: {
            beginAtZero: true,
            max: 0.35, // Adjusted for the 0.3 data peak
            ticks: { stepSize: 0.05 }
          }
        }
      }
    });
  })();
</script>

<hr />

<blockquote>
  <p><em>Figure 3.</em> The table measures the detection rates of adenomas, sessile serrated polyps, and missed adenomas. Cologuard has a slightly higher detection rate than colonoscopies in adenoma detection and a reduced detection rate in sessile serrated polyps when compared to colonoscopies. The missed adenoma rate is significantly higher in Cologuard tests than colonoscopies.</p>
</blockquote>

<h4 id="figure-4">Figure 4</h4>
<p class="note">Comparison of adenoma, sessile serrated polyp, and both sessile and adenoma detection between MT-sDNA followed by a colonoscopy versus only a colonoscopy</p>

<div style="width: 100%; max-width: 800px; margin: auto;">
  <canvas id="combinedDetectionChart"></canvas>
</div>

<script>
  (function() {
    const ctx3 = document.getElementById('combinedDetectionChart').getContext('2d');
    new Chart(ctx3, {
      type: 'bar',
      data: {
        labels: ['Adenomas', 'Sessile serrated Polyps', 'SSP + Adenoma'],
        datasets: [
          {
            label: 'Cologuard + Colonoscopy',
            data: [0.157, 0.179, 0.17], // Data for combined testing
            backgroundColor: '#c3c3c3ff', // Dark green
            borderWidth: 1
          },
          {
            label: 'Colonoscopy only',
            data: [0.04, 0.08, 0.007], // Data for colonoscopy only
            backgroundColor: '#333', // Yellow
            borderWidth: 1
          }
        ]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { position: 'bottom' },
          title: {
            display: true,
            text: 'Cologuard¬Æ and Colonoscopy vs. Colonoscopy Only: Detection Rate'
          }
        },
        scales: {
          y: {
            beginAtZero: true,
            max: 0.25, // Adjusted for the 0.179 peak
            ticks: { stepSize: 0.05 }
          }
        }
      }
    });
  })();
</script>

<hr />

<blockquote>
  <p><em>Figure 4.</em> The table graphs the detection rate of precancerous growths such as adenomas and sessile serrated polyps (SSPs) between patients who have a MT-sDNA test followed by a colonoscopy and patients who do only have a colonoscopy. Adenomas and sessile serrated polyps were detected significantly more in patients who had a MT-sDNA test followed by a colonoscopy than those who had only a colonoscopy.</p>
</blockquote>

<h3 id="discussion">Discussion</h3>
<p>Colorectal cancer ranks as the fourth most common cancer in the U.S. (2021), representing 8.9% of all cancer cases. Detecting colorectal polyps is crucial for prevention, with continous monitoring necessary even after polyp resection.</p>

<p>Colonoscopy detection rates depend significantly on intestinal cleanliness, with poor preparation reducing accuracy. Cologuard requires no preparation and, as Figure 2 demonstrates, shows higher adenoma detection and lower missed adenoma rates compared to colonoscopy. Figure 1 indicates Cologuard has comparable sensitivity and specificity to colonoscopy in detecting colon cancer, with similar impacts on reducing incidence and mortality. However, Figure 2 reveals that while Cologuard excels in adenoma detection while colonoscopy performs better in detecting invasive serrated polyps and has a significantly lower missed adenoma rate.</p>

<p>The results indicate that combining Cologuard and colonoscopy enhances overall detection rates. Cologuard effectively identifies precancerous polyps missed by colonoscopy, compensating for each test‚Äôs limitations. As Figure 3 illustrates, patients who underwent colonoscopy following Cologuard screening showed higer adenoma and invasive serrated polyp detection rates than those who had colonoscopy alone.</p>

<p>Cologuard‚Äôs non-invasive nature and 93% sensitivity compared to FIT encourages patient compliance, making it a valuable screening alternative. The findings suggest that integrating Cologuard with colonoscopy maximizes early detection effectiveness, supporting its implementation as a strategic apporach for colorectal cancer prevention.</p>

<h3 id="conclusions">Conclusions</h3>
<p>It is evident that both Cologuard(MT-sDNA) and colonoscopy serve distinct yet complementary roles in colorectal cancer(CRC) screening. Colonoscopy remains the gold standard due to its diagonostic and therapeutic capability, significantly reducing CRC incidence and mortality. However, its effectiveness can vary based on bowel preparation and provider expertise.</p>

<p>These findings reinforce prior research on the importance of balancing accuracy with accessibility in CRC screening. While colonoscopy is most appropriate for high-risk individuals, Cologuard can increase participation among average-risk populations-especially when access or willingness to undergo invasive procedures is limited.</p>

<p>To improve outcomes, future research should explore the effectiveness and cost-efficiency of hybrid models-such as using MI-sDNA as an initial screen followed by colonoscopy for positive results.</p>

<p>Ultimately, personalized and evidence-based screening strategies offer the greatest promise in reducing preventable CRC deaths worldwide.</p>]]></content><author><name>Lauren Song</name><email>ahyeonsong@ufl.edu</email></author><category term="projects" /><summary type="html"><![CDATA[Hi! This is my second research project with Undergraduate Research Society.]]></summary></entry><entry><title type="html">Education Robot</title><link href="http://localhost:4000/projects/2024-04-28-educationrobot/" rel="alternate" type="text/html" title="Education Robot" /><published>2024-04-28T00:00:00-04:00</published><updated>2026-01-08T02:46:18-05:00</updated><id>http://localhost:4000/projects/educationrobot</id><content type="html" xml:base="http://localhost:4000/projects/2024-04-28-educationrobot/"><![CDATA[<p>Manufacturing Education Robots</p>

<blockquote>
  <p>üî¨ [Project Lead] Fabian Martin, [Hardware Lead] Robert Tortolo, [Software Lead] RC Wyatte, [Test Lead] Erik Langschwager, <strong>[Design Lead] Lauren Song</strong></p>
</blockquote>

<p><strong>Timeline:</strong> : Jan 2024 - April 2024</p>

<p><strong>Key Tools:</strong> : Arduino, ThinkerCAD, Flashprint</p>

<div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>Note: Use a desktop browser to view the interactive table of contents.
</code></pre></div></div>
<ul class="large-only" id="markdown-toc">
  <li><a href="#introduction" id="markdown-toc-introduction">Introduction</a></li>
  <li><a href="#project-plan" id="markdown-toc-project-plan">Project Plan</a>    <ul>
      <li><a href="#bills-of-materials" id="markdown-toc-bills-of-materials">Bills of Materials:</a></li>
    </ul>
  </li>
  <li><a href="#prototype-design" id="markdown-toc-prototype-design">Prototype Design</a></li>
  <li><a href="#product-development" id="markdown-toc-product-development">Product development</a></li>
  <li><a href="#software-development" id="markdown-toc-software-development">Software development</a></li>
  <li><a href="#prototype-testing" id="markdown-toc-prototype-testing">Prototype testing</a></li>
  <li><a href="#recommendations" id="markdown-toc-recommendations">Recommendations</a></li>
  <li><a href="#conclusions" id="markdown-toc-conclusions">Conclusions</a></li>
  <li><a href="#references" id="markdown-toc-references">References</a></li>
</ul>

<h2 id="introduction">Introduction</h2>
<p>Our Project‚Äôs main goal is optimize the final design candidate, Wheelie, for K-12 STEM education and reduce the barriers to entry into engineering education. The purpose of this project is to broaden the diversity of learning activities for future potential enginners through the robot, Wheelie, which will be used as an educational tool.</p>

<p>By integrating various features such as sensors, motors, and interactive LCD screens that display emoji expressions, Wheelie provides hands-on learning experiences that encourage curiosity and exporation. Through the assembly process, we aim to make engineering learning enjoyable and easily accessible, while encouraging students to interactively explore concepts in robotics engineering.</p>

<p>Overall, our project, Wheelie, not only provides hands-on experience by assembling electronic components and understanding engineering theoretical concepts but also contributes to lowering the participation and entry barriers in the field of engineering, thus relating to K-12 STEM education.</p>

<h2 id="project-plan">Project Plan</h2>
<p><br /></p>

<h3 id="bills-of-materials">Bills of Materials:</h3>
<p><br /></p>

<table>
  <thead>
    <tr>
      <th>Materials</th>
      <th>Amount</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Arduino</td>
      <td>$4.27</td>
    </tr>
    <tr>
      <td>Ultrasonic Sensor</td>
      <td>$3.40</td>
    </tr>
    <tr>
      <td>Battery</td>
      <td>$2.00</td>
    </tr>
    <tr>
      <td>2/Pack DC Motors</td>
      <td>$1.80</td>
    </tr>
    <tr>
      <td>2/Pack of Wheels</td>
      <td>$3.32</td>
    </tr>
    <tr>
      <td>8GB Micro SD Card</td>
      <td>$8.29</td>
    </tr>
    <tr>
      <td>3.5‚Äù TFT LCD Display</td>
      <td>$17.83</td>
    </tr>
    <tr>
      <td><strong>Total</strong></td>
      <td><u>$39.11<u></u></u></td>
    </tr>
  </tbody>
</table>

<h2 id="prototype-design">Prototype Design</h2>
<p>The chosen design, called Wheelie, was selected over other ideas for several reasons. Its box-shaped body with a minimalist approach and an LCD screen face allow for easy assembly within a few minutes by any user, unlike other candidates that are harder to assemble. Additionally, Wheelie incorporates three wheels for stability, making it suitable for navigating indoor environments typically found in schools. Lastly, considering the customer‚Äôs budgetary constraints, our candidate design ensures cost-effectiveness, with the cost expected to be under $40.
<br /></p>

<p><img src="/assets/img/educationrobot/turtle-candidate.gif" alt="turtle" /> <img src="/assets/img/educationrobot/wheelie-candidate.gif" alt="wheelie" /></p>

<p>Based on the Figure 2, our final candidate design calculations and specific components are:</p>
<ul>
  <li>Box-shaped body</li>
  <li>LCD Screen face</li>
  <li>Two Wheels</li>
  <li>Ultrasonic Sensor</li>
  <li>Two motors</li>
  <li>Power source such as 5V battery</li>
  <li>Arduino Uno</li>
</ul>

<h2 id="product-development">Product development</h2>

<h2 id="software-development">Software development</h2>

<h2 id="prototype-testing">Prototype testing</h2>

<h2 id="recommendations">Recommendations</h2>

<h2 id="conclusions">Conclusions</h2>

<h2 id="references">References</h2>]]></content><author><name>Lauren Song</name><email>ahyeonsong@ufl.edu</email></author><category term="projects" /><summary type="html"><![CDATA[EGN 3000L]]></summary></entry><entry><title type="html">Telehealth</title><link href="http://localhost:4000/projects/2024-04-12-telehealth/" rel="alternate" type="text/html" title="Telehealth" /><published>2024-04-12T00:00:00-04:00</published><updated>2026-01-13T18:57:13-05:00</updated><id>http://localhost:4000/projects/telehealth</id><content type="html" xml:base="http://localhost:4000/projects/2024-04-12-telehealth/"><![CDATA[<p>The Potential Role and Effectiveness of Telehealth for Healthcare-deprived or Low-resource Communities Globally</p>

<blockquote>
  <p>üî¨ Maribel Serracin, Giang Ha, Chelsea Gabarron, Maria Hanna, Maddie Jarzabek, Archana Rao, <strong>Lauren Song</strong>, Gayathri Mannem</p>
</blockquote>

<p><strong>Presented at:</strong>  <a href="#">Undergraduate Research Conference at the University of South Florida</a>.</p>

<p><strong>Timeline:</strong> Oct 2023 - April 2024</p>

<p><strong>Key Tools:</strong> Rayyan</p>

<p><strong>Quick Links:</strong> <a href="/assets/img/logo/URS-Telehealth-Poster.jpg">View Poster</a></p>

<div class="language-plaintext highlighter-rouge"><div class="highlight"><pre class="highlight"><code>Note: Use a desktop browser to view the interactive table of contents.
</code></pre></div></div>
<ul class="large-only" id="markdown-toc">
  <li><a href="#research-overview" id="markdown-toc-research-overview">Research Overview</a>    <ul>
      <li><a href="#abstract" id="markdown-toc-abstract">Abstract</a></li>
      <li><a href="#introduction" id="markdown-toc-introduction">Introduction</a></li>
      <li><a href="#methods-and-materials" id="markdown-toc-methods-and-materials">Methods and Materials</a></li>
      <li><a href="#results" id="markdown-toc-results">Results</a></li>
      <li><a href="#discussion" id="markdown-toc-discussion">Discussion</a></li>
      <li><a href="#conclusions" id="markdown-toc-conclusions">Conclusions</a></li>
    </ul>
  </li>
</ul>

<h2 id="research-overview">Research Overview</h2>
<p><br /></p>

<h3 id="abstract">Abstract</h3>
<p>During and following the COVID-19 pandamic, the use of telehealth has been greatly increased due to its effectiveness in providing contactless healthcare. Telehealth has particularly shown promise in reaching people who cannot access in-person healthcare due to reasons incuding but not limited to scarcity of neaby medical centers, lack of transportion, and lack of finances.</p>

<p>This systematic review evaluates experimental and review articles to determine the global impact and effectiveness of telehealth practices. The results of this review demonstrated that telehealth has greatly improved accessbility and facilitating easy access to information through e-record systems.</p>

<p>Telehealth has also made improvements in quality of care for underserved populations and in closing the healthcare gap between urban and rural patients. Telehealth has been particularly beneficial in areas such as cancer screenings, chronic condition management, addressing acute medical emergencies, and pediatric care.</p>

<p>However, research has also found that while telehealth can close mobility and transportation gaps, disparities due to insufficient internet, lack of access to devices, and language barriers continue to persis.</p>

<p>Overall, this review has determined that telehealth has significant benefits for improving access to and quality of medical care, especially for people in rural or underserved areas. However, it is important to address continuing disparities through further research such as by exploring training for healthcare professionals and investigatin how to close telehealth-related barriers for certain demographics such as older adults and racial and ethnic minorities.</p>

<h3 id="introduction">Introduction</h3>
<p>The COVID-19 pandemic has changed the landscape of healthcare delivery worldwide, fostering the expansion of telehealth. Telehealth utilization represents an adaptation to the challenges of providing continous healthcare admist restrctions on physical mobility and social distancing. The pandemic have thrust telehealth to the forefront, showcasing its potential to bridge gaps in access to healthcare services. The shift towards telehealth opened new avenues for patient care, extending reach of medical services to populations that previously faced substantial barriers to access.</p>

<p>This review aims to assess the global impact and effectiveness of telehealth practices during and follwong the pandemic, evaluating its role in enhancing accessbility, quality of care, and its potential in mitigating healthcare disparities.</p>

<p>By analyzing scholarly articles, it seeks to understand how telehealth has improved healthcare accessbility and quality, especially for those previously hindered by distance, transportation issues, or financial limitations, while also acknowledging ongoing disparities such as internet access, device availability, and language barriers. The review intends to offer insights into telehealth‚Äôs benefits and areas requiring further research to enhance its equity and effectiveness across all demographics.</p>

<h3 id="methods-and-materials">Methods and Materials</h3>
<p>Articles discussing the effects of telehealth on healthcare-deprived and low-resource communities were collected and screened throguh Rayyan. A systematic review was then conducted to filter through various study methods and variables to determine relevancy to the research topic.</p>

<div style="position: relative; width: 100%; max-width: 800px; margin: 0 auto;">
  <svg width="100%" height="750" viewBox="0 0 800 750" xmlns="http://www.w3.org/2000/svg">
    <defs>
      <marker id="arrowhead2" markerWidth="10" markerHeight="7" refX="0" refY="3.5" orient="auto">
        <polygon points="0 0, 10 3.5, 0 7" fill="#333" />
      </marker>
    </defs>

    <rect x="10" y="40" width="60" height="120" fill="#f0f0f0" />
    <text x="40" y="100" transform="rotate(-90 40,100)" fill="#333" font-size="14" text-anchor="middle">Identification</text>
    <rect x="10" y="170" width="60" height="150" fill="#f0f0f0" />
    <text x="40" y="245" transform="rotate(-90 40,245)" fill="#333" font-size="14" text-anchor="middle">Screening</text>
    <rect x="10" y="330" width="60" height="230" fill="#f0f0f0" />
    <text x="40" y="445" transform="rotate(-90 40,445)" fill="#333" font-size="14" text-anchor="middle">Eligibility</text>
    <rect x="10" y="570" width="60" height="150" fill="#f0f0f0" />
    <text x="40" y="645" transform="rotate(-90 40,645)" fill="#333" font-size="14" text-anchor="middle">Included</text>

    <g class="prisma-step" id="step1" style="cursor: pointer;">
      <rect x="150" y="40" width="300" height="80" fill="#fff" stroke="#333"></rect>
      <text x="300" y="75" text-anchor="middle" font-size="14">Record obtained through</text>
      <text x="300" y="95" text-anchor="middle" font-size="14">database search (n=425)</text>
    </g>

    <line x1="300" y1="120" x2="300" y2="150" stroke="#333" marker-end="url(#arrowhead2)"></line>

    <g class="prisma-step" id="step2" style="cursor: pointer;">
      <rect x="150" y="150" width="300" height="80" fill="#fff" stroke="#333"></rect>
      <text x="300" y="185" text-anchor="middle" font-size="14">Records after duplicates removed</text>
      <text x="300" y="205" text-anchor="middle" font-size="14">(n=388)</text>
    </g>

    <line x1="300" y1="230" x2="300" y2="260" stroke="#333" marker-end="url(#arrowhead2)"></line>

    <g class="prisma-step" id="step3" style="cursor: pointer;">
      <rect x="150" y="260" width="300" height="80" fill="#fff" stroke="#333"></rect>
      <text x="300" y="305" text-anchor="middle" font-size="14">Records screened (n=299)</text>
    </g>

    <line x1="300" y1="340" x2="300" y2="370" stroke="#333" marker-end="url(#arrowhead2)"></line>
    <line x1="450" y1="300" x2="520" y2="300" stroke="#333" marker-end="url(#arrowhead2)"></line>

    <g class="prisma-step" id="step3-ex" style="cursor: pointer;">
      <rect x="520" y="260" width="220" height="80" fill="#fff" stroke="#333"></rect>
      <text x="630" y="295" text-anchor="middle" font-size="14">Records excluded</text>
      <text x="630" y="315" text-anchor="middle" font-size="14">(n=93)</text>
    </g>

    <g class="prisma-step" id="step4" style="cursor: pointer;">
      <rect x="150" y="370" width="300" height="100" fill="#fff" stroke="#333"></rect>
      <text x="300" y="405" text-anchor="middle" font-size="14">Full-text articles</text>
      <text x="300" y="425" text-anchor="middle" font-size="14">assessed for eligibility</text>
      <text x="300" y="445" text-anchor="middle" font-size="14">(n=206)</text>
    </g>

    <line x1="300" y1="470" x2="300" y2="580" stroke="#333" marker-end="url(#arrowhead2)"></line>
    <line x1="450" y1="420" x2="520" y2="420" stroke="#333" marker-end="url(#arrowhead2)"></line>

    <g class="prisma-step" id="step4-ex" style="cursor: pointer;">
      <rect x="520" y="370" width="250" height="180" fill="#fff" stroke="#333"></rect>
      <text x="645" y="400" text-anchor="middle" font-size="14">Full-text articles excluded,</text>
      <text x="645" y="420" text-anchor="middle" font-size="14">with reasons (n=134):</text>
      <text x="645" y="455" text-anchor="middle" font-size="13">- Out of scope (n=89)</text>
      <text x="645" y="480" text-anchor="middle" font-size="13">- Inappropriate methods (n=10)</text>
      <text x="645" y="505" text-anchor="middle" font-size="13">- Insufficient detail (n=35)</text>
    </g>

    <g class="prisma-step" id="step5" style="cursor: pointer;">
      <rect x="150" y="580" width="300" height="100" fill="#fff" stroke="#333"></rect>
      <text x="300" y="625" text-anchor="middle" font-size="14">Studies included in</text>
      <text x="300" y="645" text-anchor="middle" font-size="14">qualitative synthesis (n=72)</text>
    </g>
  </svg>

  <div id="final-tooltip" style="position: fixed; display: none; background: #333; color: #fff; padding: 10px; border-radius: 5px; font-size: 13px; z-index: 1000; pointer-events: none; max-width: 280px; box-shadow: 2px 2px 10px rgba(0,0,0,0.2);"></div>
</div>

<script>
  (function() {
    const tooltip = document.getElementById('final-tooltip');
    const boxData = {
      'step1': '<strong>Identification:</strong> Total records found through database searches.',
      'step2': '<strong>Refinement:</strong> 388 records remaining after 37 duplicates were removed.',
      'step3': '<strong>Screening:</strong> Titles and abstracts screened for basic inclusion criteria.',
      'step3-ex': '<strong>Excluded:</strong> 93 records failed to meet initial screening requirements.',
      'step4': '<strong>Full-text Review:</strong> 206 articles assessed in detail for eligibility.',
      'step4-ex': '<strong>Excluded with Reasons:</strong><br/>- Out of scope (n=89)<br/>- Inappropriate methods (n=10)<br/>- Insufficient detail (n=35)',
      'step5': '<strong>Final Selection:</strong> 72 studies included in the qualitative synthesis.'
    };

    
    document.querySelectorAll('.prisma-step').forEach(step => {
      step.addEventListener('mouseenter', (e) => {
        tooltip.innerHTML = boxData[step.id];
        tooltip.style.display = 'block';

        step.querySelector('rect').style.fill = '#f0f0f0';
      });

      step.addEventListener('mousemove', (e) => {
        tooltip.style.left = (e.clientX + 15) + 'px';
        tooltip.style.top = (e.clientY + 15) + 'px';
      });

      step.addEventListener('mouseleave', () => {
        tooltip.style.display = 'none';
        step.querySelector('rect').style.fill = '#fff';
      });
    });
  })();
</script>

<!-- <br>


<div style="width: 100%;"><div style="position: relative; padding-bottom: 56.25%; padding-top: 0; height: 0;"><iframe title="Identification" frameborder="0" width="1200" height="675" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;" src="https://view.genially.com/695a2506838daacff3cc57fd" type="text/html" allowscriptaccess="always" allowfullscreen="true" scrolling="yes" allownetworking="all"></iframe> </div> </div> -->

<h3 id="results">Results</h3>

<table>
  <thead>
    <tr>
      <th>Authors</th>
      <th>Year</th>
      <th>Title</th>
      <th>Journal</th>
      <th>Type of Study</th>
      <th>Main Findings</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Ramirez, et al.</td>
      <td>2020</td>
      <td>Telemedicine in Minority and Socioeconomically Disadvantaged Communities Amidst COVID-19 Pandemic</td>
      <td>NCBI</td>
      <td>Literature Review</td>
      <td>Cultural views influence attitudes; minorities chose Telehealth due to linguistic/economic barriers to in-person care.</td>
    </tr>
    <tr>
      <td>Rush, et al.</td>
      <td>2022</td>
      <td>Telehealth Use for Enhancing the Health of Rural Older Adults: A Systematic Mixed Studies Review</td>
      <td>NCBI</td>
      <td>Systemic Review</td>
      <td>Telehealth is a cost-efficient method for rural healthcare compared to traditional consultations.</td>
    </tr>
    <tr>
      <td>Ramsey, et al.</td>
      <td>2023</td>
      <td>Children with uncontrolled asthma from economically disadvantaged neighborhoods‚Ä¶</td>
      <td>NCBI</td>
      <td>Literature Review</td>
      <td>60-70% of children with asthma miss appointments due to transport; Telehealth enables home-based treatment.</td>
    </tr>
    <tr>
      <td>Jaffe et al.</td>
      <td>2020</td>
      <td>Health Inequalities in the Use of Telehealth in the United States in the Lens of COVID-19</td>
      <td>NCBI</td>
      <td>Literature review</td>
      <td>Majority were mental health seekers; rural use lower than urban; 845% surge in outpatient Telehealth during COVID.</td>
    </tr>
    <tr>
      <td>Schwamm et al.</td>
      <td>2014</td>
      <td>Telehealth: Seven Strategies To Successfully Implement Disruptive Technology</td>
      <td>Health affairs</td>
      <td>Literature Review</td>
      <td>7 success strategies: patient/provider expectations, revenue models, deconstructing traditional care, etc.</td>
    </tr>
    <tr>
      <td>Bowman et al.</td>
      <td>2022</td>
      <td>The ‚ÄúTelehealth Divide‚Äù‚ÄîWho Are the Underserved, and What Care Is Improved?</td>
      <td>JABFM</td>
      <td>Systematic Review</td>
      <td>Examines racial disparities in wellness, visits, drug safety, and medical abortion post-pandemic.</td>
    </tr>
    <tr>
      <td>Glassman Paul</td>
      <td>2012</td>
      <td>Using Telehealth Technologies to Improve Oral Health for Vulnerable‚Ä¶</td>
      <td>JCDA</td>
      <td>Literature Review</td>
      <td>Emerging evidence that telehealth enhances oral health delivery for vulnerable/underserved populations.</td>
    </tr>
    <tr>
      <td>Ghaddar Suad</td>
      <td>2020</td>
      <td>Understanding the Intention to Use Telehealth Services in Underserved Hispanic Border Communities</td>
      <td>JMIR</td>
      <td>Systematic Review</td>
      <td>Measured attitudes at Texas-Mexico border; Telehealth literacy fosters positive feelings toward the service.</td>
    </tr>
    <tr>
      <td>Jewitt et al.</td>
      <td>2021</td>
      <td>Telehealth: Reducing or increasing cancer care disparities?</td>
      <td>JCO</td>
      <td>Systematic Review</td>
      <td>Shows disparities among historically underserved cancer patients of varying ethnicities and ages.</td>
    </tr>
    <tr>
      <td>Flack Paul et al.</td>
      <td>2004</td>
      <td>Addressing Mental Health needs of the rural underserved</td>
      <td>Contemporary Family Therapy</td>
      <td>Literature Review</td>
      <td>Mental health services effectively delivered via distance tech; requires tech accommodations for both parties.</td>
    </tr>
    <tr>
      <td>Marcin et al.</td>
      <td>2015</td>
      <td>Addressing health disparities in rural communities using telehealth</td>
      <td>Pediatric Research</td>
      <td>Literature Review</td>
      <td>Improves satisfaction and reduces costs; addresses geographic maldistribution of pediatric specialists.</td>
    </tr>
    <tr>
      <td>Bailey et al.</td>
      <td>2021</td>
      <td>Early Patient-Centered Outcomes Research Experience With the Use of Telehealth to Address Disparities</td>
      <td>JMIR</td>
      <td>Literature Review</td>
      <td>Disparities reduced by patient-centered care and strong provider-patient connections.</td>
    </tr>
    <tr>
      <td>Chambers et al.</td>
      <td>2012</td>
      <td>A cross-sectional survey and service evaluation of simple telehealth in primary care</td>
      <td>BMJ</td>
      <td>Systematic Review</td>
      <td>High satisfaction; easy to use; schedule flexibility and improved hypertension education in general population.</td>
    </tr>
    <tr>
      <td>Ahmed et al.</td>
      <td>2015</td>
      <td>Portable Health Clinic: A Telehealthcare System for UnReached Communities</td>
      <td>SpringerLink</td>
      <td>Original research</td>
      <td>Successful in Bangladesh for NCDs/aging; reduces morbidity; drawback: cannot handle communicable diseases.</td>
    </tr>
    <tr>
      <td>Sammy Le et al.</td>
      <td>2021</td>
      <td>The application of telehealth to remote and rural Australians with chronic neurological conditions</td>
      <td>Wiley</td>
      <td>Original research</td>
      <td>Rural Australians highly satisfied; 100% would recommend; beneficial for chronic conditions without re-exam.</td>
    </tr>
    <tr>
      <td>Hochman et al.</td>
      <td>2000</td>
      <td>Cardiogenic shock complicating acute myocardial infarction‚Äìetiologies‚Ä¶</td>
      <td>Elsevier</td>
      <td>Original research</td>
      <td>Smartphone-paired ECG/Echo in Zimbabwe; data sent to US specialists; identified CVD in high-risk populations.</td>
    </tr>
    <tr>
      <td>Thota et al.</td>
      <td>2020</td>
      <td>Telehealth is a Sustainable Population Health Strategy to Lower Costs‚Ä¶</td>
      <td>ASCO</td>
      <td>Original research</td>
      <td>Saves time/money for rural Utah patients; barriers include staffing, training, and maintenance.</td>
    </tr>
    <tr>
      <td>Vadheim et al.</td>
      <td>2017</td>
      <td>Telehealth delivery of the diabetes prevention program to rural communities</td>
      <td>Oxford Academic</td>
      <td>Original research</td>
      <td>Comparable results to on-site programs in weight loss/participation for rural communities.</td>
    </tr>
    <tr>
      <td>Moffatt &amp; Eley</td>
      <td>2010</td>
      <td>The reported benefits of telehealth for rural Australians</td>
      <td>CSIRO Publishing</td>
      <td>Original research</td>
      <td>Potential to reduce access lack in rural Australia; requires practitioner upskilling for implementation.</td>
    </tr>
  </tbody>
</table>

<h3 id="discussion">Discussion</h3>
<p>The latest study underscores the positive impacts of telehealth utilization within communities, especially those catering to healthcare-deprived or low-resource demographics. However, it also brings attention to pertinent issues, particularly from an economic standpoint, as the costs of essential telehealth equipment pose a significant challenge.</p>

<p>By addressing these challenges directly, it can be ensured that telehealth‚Äôs influential promise is fulfilled, resulting in more equitable access to healthcare services for all individuals, regardless of geographical location or socioecnomic status.</p>

<h3 id="conclusions">Conclusions</h3>
<p>Telehealth initiatives have demonstrated significant strides in extending their reach to underserved populations, including within developing nations where technology adoption remains sparse. Health care professionals advocate for Telehealth, asserting that the caliber of care delivered via this digital platform is commensurate with that of traditional in-person consultations. Its applicability ranges from chronic disease management to acute emergency situations, enhancing accessibility and quality of healthcare services. Moreover, with the improved accessbility of medical information through research programs like INvest clinical trials and initiatives like GIVE, remote healthcare services are expanding. For example, a study conducted revealed that more than half of children who suffer from asthma fail to attend their in-person medical appointments due to transportation difficulties.</p>

<p>Telehealth has played a crucial role in overcoming these financial and logistical obstacles, enabling families globally to access medical care from a physician without the burdens that traditionally hinder patient care. The findings from scholarly articles provide insightful and quantitative evidence on Telehealth‚Äôs positive effect on various communities, such as low-income families and the elderly.</p>]]></content><author><name>Lauren Song</name><email>ahyeonsong@ufl.edu</email></author><category term="projects" /><summary type="html"><![CDATA[Hi! This is my first research at the University of South Florida with Undergraduate Research Society.]]></summary></entry><entry><title type="html">Notes</title><link href="http://localhost:4000/projects/2022-05-04-notes/" rel="alternate" type="text/html" title="Notes" /><published>2022-05-04T00:00:00-04:00</published><updated>2026-01-03T03:09:55-05:00</updated><id>http://localhost:4000/projects/notes</id><content type="html" xml:base="http://localhost:4000/projects/2022-05-04-notes/"><![CDATA[<p>Check out interesting articles!</p>

<!-- <span class="icon-twitter-old"></span> ‚Üí <span class="icon-twitter"></span>
{:.larger} -->

<!--more-->


<!-- ## 2026
Happy New Year! `2026`.
{:.note.smaller} -->

<p><a href="https://www.health.harvard.edu/mind-and-mood/can-our-brain-talk-to-our-immune-system">Can our brain talk to our immune system?</a></p>

<!-- Why Immune System is Interesting?
Youth is not forever, the engine of our lives is immune system.


I've been interested in immune system since I was young, however, it gets bigger since I moved all around the world. Depends on my immune system and each different environemnt gave me special occaision disease. The medical settings can be easily to understand when you are in the situations, and experiences how the small amount of different from normal life can affect your life big. -->]]></content><author><name>Lauren Song</name><email>ahyeonsong@ufl.edu</email></author><category term="projects" /><summary type="html"><![CDATA[Documenting sincce 2022.]]></summary></entry></feed>